reviewMolecular TherapyJan 12, 2016HYBRID OA

Genome-editing Technologies for Gene and Cell Therapy

Editas Medicine (United States) · Duke University · +1 more institution

PubMed
Indexed incrossrefpubmed

Abstract

Gene therapy has historically been defined as the addition of new genes to human cells. However, the recent advent of genome-editing technologies has enabled a new paradigm in which the sequence of the human genome can be precisely manipulated to achieve a therapeutic effect. This includes the correction of mutations that cause disease, the addition of therapeutic genes to specific sites in the genome, and the removal of deleterious genes or genome sequences. This review presents the mechanisms of different genome-editing strategies and describes each of the common nuclease-based platforms, including zinc finger nucleases, transcription activator-like effector nucleases (TALENs), meganucleases, and the…

Citation impact

716
total citations
FWCI
51.18
Percentile
100%
References
303
Citations per year

Authors

2

Topics & keywords

Keywords
  • Genome editing
  • Zinc finger nuclease
  • Transcription activator-like effector nuclease
  • Genome
  • Biology
  • CRISPR
  • Genome engineering
  • Gene
No related works found for this paper.